Association of depression and suicidal behaviour reporting with HIV integrase inhibitors: a global pharmacovigilance study.

Laure-Hélène PrétaTomasz ChroboczekJean-Marc TreluyerLaurent Chouchana

Published in: The Journal of antimicrobial chemotherapy (2023)

Our findings suggest that depression and suicidality are adverse drug reactions of all INSTI agents, especially dolutegravir, which may occur within the first months of therapy.

Keyphrases

adverse drug
depressive symptoms
antiretroviral therapy
electronic health record
emergency department
sleep quality
hiv positive
drug induced
human immunodeficiency virus
hepatitis c virus
hiv aids
stem cells